DEA Rushes Dangerous, Addictive ADHD Drugs to Market to Meet Demand
Alert the media! Get Dan Rather on the phone! The United States of America is having a problem producing enough legal, yet highly addictive, and dangerous, mind-altering drugs that are alleged to “treat” attention deficit hyperactivity disorder (ADHD).
The Drug Enforcement Administration (DEA), the federal agency that oversees drug distribution of Controlled Substances, is responsible for setting quotas and controlling the amount of drug that may be legally produced. In this case, there apparently was a shortfall of ADHD medications in 2022 because there was an enormous increase in the diagnosis of ADHD during the Covid Pandemic and the pharmaceutical manufacturers failed to produce the full amount of approved drug, causing a one billion dose shortfall for 2023 and the great catch-up ensued. One billion doses. Geesh! A billion here and a billion there and pretty soon we’re talking about real drugging!
